Brinzolamide/Brimonidine Combination vs Brimonidine 0.2% in the Prevention of IOP Rise After Nd-YAG Laser Capsulotomy

NCT03192826 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

79

Enrollment

OTHER

Sponsor class

Conditions

Posterior Capsule Opacification
Ocular Hypertension

Interventions

DRUG: Brinzolamide/Brimonidine FC
DRUG: Brimonidine 0.2%
DRUG: Artificial tears

Sponsor

University Hospital of Patras